China Pharmaceutical Equipment Industry Report, 2012-2015
  • Mar.2013
  • Hard Copy
  • USD $2,100
  • Pages:81
  • Single User License
    (PDF Unprintable)       
  • USD $2,000
  • Code: XJT028
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $3,100
  • Hard Copy + Single User License
  • USD $2,300
Driven by the new GMP certification as well as the brisk downstream demand, China pharmaceutical equipment industry has seen steady progress in sales volume and technological content of products over the years, with industrial sales showing a rapid growth trend. In line with statistics of the China Association for Pharmaceutical Equipment, in 2011 the pharmaceutical equipment industry of China achieved gross industrial output value of RMB15.84 billion, a year-on-year increase of 23.5%; sales of RMB16.1 billion, up 25.2% year-on-year; total profit of RMB1.818 billion, up 19.3% YoY; and gross margin of the industry rose to 11.3%.

Sales of China Pharmaceutical Equipment Industry, 2005-2012

For now, the leading companies in Chinese pharmaceutical equipment industry are primarily concentrated in drying, packaging and sterilization areas, such as Shinva Medical Instrument Co., Ltd., Shanghai Tofflon Science and Technology Co., Ltd., Truking Technology Limited,? and Hunan China Sun Pharmaceutical Machinery Co., Ltd.. According to the new GMP regulations and the enforcement of pharmaceutical companies, 2011-2012 is a rapid growth period for China pharmaceutical equipment industry; as the certification ends in 2015, industry revenue growth in 2013-2014 will slow down. It is expected that in 2015, sales of China pharmaceutical equipment industry will attain to RMB31.41 billion.

Chinese pharmaceutical equipment enterprises generally adopt the customized business model, with a relatively low industry concentration. In recent years, market share of the top four enterprises (CR4) is maintained at about 25%. In 2011, Shinva Medical in the first position obtained the revenue of RMB2.1061 billion, with market share up to 13.1%.

China Pharmaceutical Equipment Industry Report, 2012-2015 mainly covers the followings:

20120114.gif Status analysis, including industry development, industry concentration, entry barriers, competition pattern, technical status and development trend, etc.;
20120114.gif Development environment analysis, involving regulatory system, regulatory policies, industry policies, influences from upstream and downstream sectors, etc.;
20120114.gif Market size prediction, concerning three key market segments i.e. sterilization equipment, drying equipment, and large-volume infusion production line, as well as corporate development mode, market competition trends, and so on;
20120114.gif Production, operation, investment, M&A, development forecast, etc. of ten Chinese pharmaceutical equipment enterprises like Shinva Medical, Tofflon, Truking Technology and Hunan China Sun.
1. Overview of Pharmaceutical Equipment Industry
1.1 Definition
1.2 Classification

2. Status Quo of China Pharmaceutical Equipment Industry
2.1 Development
2.1.1 Sales
2.1.2 Profit
2.1.3 Asset Utilization
2.1.4 Exports
2.1.5 Market Demand
2.2 Market Competition
2.2.1 Industry Concentration
2.2.2 Entry Barriers
2.2.3 SWOT
2.3 Technical Status and Development Trend
2.3.1 Status Quo and Characteristics
2.3.2 Development Trend

3. Development Environment of China Pharmaceutical Equipment Industry
3.1 Policy Environment
3.1.1 Regulatory System
3.1.2 Industrial Policy
3.2 Upstream and Downstream Industries
3.2.1 Industrial Chain Structure
3.2.2 Upstream
3.2.3 Downstream

4. Development Forecast of China Pharmaceutical Equipment Industry
4.1 Market Size 
4.1.1 Periodic Analysis
4.1.2 New GMP Transformation Cost Analysis
4.1.3 Market Size Estimates
4.2 Key Market Segments
4.2.1 Sterilization Equipment Market
4.2.2 Drying Equipment Market
4.2.3 Large-volume Infusion Production Line Market 
4.3 Development Trends
4.3.1 Rapid Development of Leading Enterprises through M&A
4.3.2 Product Line Development towards Systemization 
4.3.3 Import Substitution in High-end Market

5. Key Enterprises
5.1 Shinva Medical
5.1.1 Profile
5.1.2 Operation
5.1.3 Revenue Structure
5.1.4 Gross Margin
5.1.5 Investment
5.1.6 Main Business
5.1.7 Prediction & Prospects
5.2 Tofflon
5.2.1 Profile
5.2.2 Operation
5.2.3 Revenue Structure
5.2.4 Gross Margin
5.2.5 R&D and Investment
5.2.6 Pharmaceutical Equipment Business
5.2.7 Prediction & Prospects
5.3 Hunan China Sun
5.3.1 Profile
5.3.2 Operation
5.3.3 Revenue Structure
5.3.4 Gross Margin
5.3.5 R&D and Investment
5.3.6 Main Business
5.3.7 Prediction & Prospects
5.4 Truking Technology
5.4.1 Profile
5.4.2 Operation
5.4.3 Revenue Structure
5.4.4 Gross Margin
5.5 Beijing Double-crane Pharmaceutical Equipment Co., Ltd.
5.5.1 Profile
5.5.2 Operation
5.6 Harbin Nano Pharmaceutical & Chemical Equipment Co., Ltd
5.6.1 Profile
5.6.2 Operation
5.7 Shanghai Far-East Pharmaceutical Machinery Co.,Ltd
5.7.1 Profile
5.7.2 Operation
5.8 Wenzhou Yaguang Machinery Manufacturing Co., Ltd
5.8.1 Profile
5.8.2 Operation
5.9 Jiangsu Saideli Pharmaceutical Machinery Manufacture Co. Ltd.
5.9.1 Profile
5.9.2 Operation
5.10 Hualian Pharmaceutical Machinery Co.,Ltd
5.10.1 Profile
5.10.2 Operation

Classification of Pharmaceutical Equipment Industry
Gross Industrial Output Value of China Pharmaceutical Equipment Industry, 2005-2012
Sales of China Pharmaceutical Equipment Industry, 2005-2012
Product Sales Volume of China Pharmaceutical Equipment Industry, 2008-2011
Total Profit of China Pharmaceutical Equipment Industry, 2005-2012
Return on Sales of China Pharmaceutical Equipment Industry, 2005-2012
Average Balance and Turnover Rate of Current Assets of China Pharmaceutical Equipment Industry, 2005-2012
Export Delivery Value and % of Sales of China Pharmaceutical Equipment Industry, 2005-2012
China Pharmaceutical Enterprise Classification and Market Demand
Market Share of Top 10 Chinese Pharmaceutical Equipment Enterprises by Sales, 2009
Main Business and Competitive Advantages of Top Enterprises of China Pharmaceutical Equipment Industry
Policies and Main Content of China Pharmaceutical Equipment Industry, 2001-2012
Pharmaceutical Equipment Industry Chain
Development Process of the World Pharmaceutical Industry
China Steel Production, 2005-2012
China Steel Composite Price Index, 2011-2013
Number of Chinese Pharmaceutical Manufacturers, 2005-2012
Operating Revenue of China Pharmaceutical Manufacturing, 2005-2012
Total Investment in Fixed Assets and Growth of China Pharmaceutical Manufacturing, Jan-Sep 2011
Output of Chemical Raw Medicine in China, 2006-2012
Output of Chinese Patent Medicine in China, 2006-2012
China Pharmaceutical Equipment Industry Cycles
Revenue of China Pharmaceutical Equipment Industry, 2005-2015E
Applications and Major Equipments of Common Sterilization Methods in Pharmaceutical Industry
China’s Major Sterilization Equipment Enterprises and Products
Sales Volume of Sterilization Equipments in China, Jan-Sep 2011
Sales Volume of Sterilization Equipments in China, 2008-2015
Common Sterilization Equipments in Pharmaceutical Industry
Bid Prices of Kunming Pharmaceutical’s Xuesaitong Lyophilized Powder Injection (Part)
Bid Prices of Kunming Pharmaceutical’s Xuesaitong Squirt Cut (Part)
Major Enterprises and Products of China Lyophilization System Market, 2011
China Lyophilizer Sales Volume, 2008-2015
Estimates for Lyophilization Industry Upgrading
Stage of EU and US Large-volume Infusion Product Development
Sales Volume of Infusion Products in China by Packages, 2005-2010
Major Enterprises and Products of China Large-volume Infusion Production Line
Market Share and Suppliers of China’s Top 10 Large-volume Infusion Manufacturers, 2007
Sales Volume of China Large-volume Infusion Production Line, 2008-2015E
Development Stage and Key Events of IMA’s Main Business
Main Products and Development Trends of Listed Companies in China Pharmaceutical Equipment Industry
Revenue and Net Income of Shinva Medical, 2008-2012
Revenue Breakdown of Shinva Medical by Product, 2008-2012
Revenue Breakdown of Shinva Medical by Region, 2008-2012
Gross Margin of Shinva Medical by Product, 2008-2012
Investment Projects and Investment Amount of Shinva Medical, 2011
Main Products and Industry Status of Shinva Medical, 2012
Revenue and Net Income of Shinva Medical, 2011-2014
Revenue and Net Income of Tofflon, 2008-2012
Revenue Breakdown of Tofflon by Product, 2008-2012
Revenue Breakdown of Tofflon by Region, 2008-2012
Gross Margin of Tofflon by Product, 2008-2012
R&D Costs and % of Total Revenue of Tofflon, 2008-2012
Investment Projects and Investment Amount of Tofflon, 2011
Tofflon’s Revenue from Replacement and Transformation of 1,500 Freeze Dryers Sold
Revenue and Net Income of Tofflon, 2011-2014
Revenue and Net Income of Hunan China Sun, 2008-2012
Revenue Breakdown of Hunan China Sun by Product, 2008-2012
Revenue Breakdown of Hunan China Sun by Region, 2008-2012
Gross Margin of Hunan China Sun by Product, 2008-2012
Investment Projects and Investment Amount of Hunan China Sun, 2011
R&D Costs and % of Total Revenue of Hunan China Sun, 2008-2011
Independent  R&D Technologies and Advantages of Hunan China Sun
Revenue and Net Income of Hunan China Sun, 2011-2014E
Revenue and Total Profit of Truking Technology, 2009-2011
Revenue Breakdown of Truking Technology by Product, 2009-2011
Revenue Breakdown of Truking Technology by Region, 2009-2011
Gross Margin of Truking Technology by Product, 2009-2011
Main Products of Beijing Double-crane Pharmaceutical Equipment Co., Ltd.
Revenue and Total Profit of Beijing Double-crane Pharmaceutical Equipment Co., Ltd., 2007-2011
Gross Margin of Beijing Double-crane Pharmaceutical Equipment Co., Ltd., 2007-2009
Total Assets and Total Liabilities of Beijing Double-crane Pharmaceutical Equipment Co., Ltd., 2007-2009
Revenue and Total Profit of Harbin Nano Pharmaceutical & Chemical Equipment Co., Ltd, 2007-2009
Gross Margin of Harbin Nano Pharmaceutical & Chemical Equipment Co., Ltd., 2007-2009
Total Assets and Total Liabilities of Harbin Nano Pharmaceutical & Chemical Equipment Co., Ltd., 2007-2009
Revenue and Total Profit of Shanghai Far-East Pharmaceutical Machinery Co.,Ltd, 2007-2008
Gross Margin of Shanghai Far-East Pharmaceutical Machinery Co.,Ltd., 2007-2008
Total Assets and Total Liabilities of Shanghai Far-East Pharmaceutical Machinery Co.,Ltd., 2007-2008
Revenue and Total Profit of Wenzhou Yaguang Machinery Manufacturing Co., Ltd., 2007-2009
Gross Margin of Wenzhou Yaguang Machinery Manufacturing Co., Ltd., 2007-2009
Total Assets and Total Liabilities of Wenzhou Yaguang Machinery Manufacturing Co., Ltd., 2007-2009
Revenue and Total Profit of Jiangsu Saideli Pharmaceutical Machinery Manufacture Co. Ltd., 2007-2009
Gross Margin of Jiangsu Saideli Pharmaceutical Machinery Manufacture Co. Ltd., 2007-2009
Total Assets and Total Liaiblities of Jiangsu Saideli Pharmaceutical Machinery Manufacture Co. Ltd., 2007-2009
Revenue and Total Profit of Hualian Pharmaceutical Machinery Co., Ltd., 2007-2009
Gross Margin of Hualian Pharmaceutical Machinery Co.,Ltd., 2007-2009
Total Assets and Total Liabilities of Hualian Pharmaceutical Machinery Co.,Ltd., 2007-2009

China Contract Research Organization (CRO) Industry Report, 2020-2026

The contract research organization (CRO) industry has been galloping amid the global pharmaceutical market steadily in head way, the vibrant financing in the medical and health sector, and the prolife...

China Human Vaccine Industry Report, 2020-2026

In China, the lot release for human vaccines plunged by 17.7% in 2018 when the production record fraud of rabies vaccines for human use, freeze-dried by Changsheng Bio-Technology was exposed. The impa...

China Pharmaceutical Distribution Industry Report, 2019-2026

The Chinese pharmaceutical distribution market has been expanding steadily over the recent years, being valued at RMB2,330.3 billion in 2019 with a year-on-year increase of 8.9%, of which the pharmace...

China Pharmaceutical Distribution Industry Report, 2019-2025

China’s pharmaceutical distribution industry has sustained steady growth over the years. In 2018, the market was worth RMB2,194.5 billion, a 9.6% rise from RMB2,001.6 billion (up by 8.4% YoY) in 2017,...

China Pharmaceutical Packaging Industry Report, 2019-2025

Being incentivized by the burgeoning pharmaceuticals industry, Chinese pharmaceutical packaging market size sustained growth rates of around 10% in recent years, and outstripped RMB100 billion in 2018...

China Blood Product Industry Report, 2018-2022

The blood product industry in China develops under stimulation of industry policies and downstream demand. The country recorded total lot release volume of 64.11 million bottles of blood products in 2...

China Pharmaceutical Distribution Industry Report, 2017-2021

The Chinese pharmaceutical distribution market has developed steadily but at a slower rate in recent years. The industry rose by 10.4% year on year to RMB1.8393 trillion in 2016 and is expected to hit...

China Blood Product Industry Report, 2017-2021

China’s blood product market size mushroomed in 2016 under the impetus of liberalization of limited-price policy, price rises in varying degrees and lot release volume growth for blood products in 201...

China Pharmaceutical Packaging Industry Report, 2016-2021

Under the impetus of the fast-growing downstream pharmaceutical industry, Chinese pharmaceutical packaging market size increased year by year at the CAGR of 11.2% during 2010-2016. From 2017 to 2021, ...

China Pharmaceutical Glass Packaging Industry Report, 2014-2017

In recent years, advances in new healthcare reform have boosted market demand from China pharmaceuticals industryand driven growth in the demand from pharmaceutical packaging industry. In 2014, the Ch...

China Vitamin Industry Report,2014-2017

China is the world's largest production base of vitamins, with vitamin C and vitamin E as its most important products, wherein vitamin C and related products account for more than 60% of its total out...

China Chemical Pharmaceutical Industry Report, 2013-2016

Chemical pharmaceutical consists mainly of chemical drug preparation and active pharmaceutical ingredient (API), and the gross margin of chemical drug preparation industry is generally higher than tha...

China Pharmaceutical Distribution Industry Report, 2013

Thanks to the continuous advancement in new medical reform, China’s pharmaceutical distribution industry has maintained a fairly rapid growth in recent years, with the sales value showed a CAGR of rou...

China Pharmaceutical Glass Packaging Industry Report, 2013-2016

Influenced by the substitution of plastic, aluminum foil and other new packaging materials as well as the declining packaging material purchase prices incurred by the medical reform, China pharmaceuti...

China Chinese Patent Medicine Industry Report, 2013-2016

Chinese patent medicine refers to the certain dosage forms of medicine, under the guidance of TCM (traditional Chinese medicine) theory, made from traditional Chinese medicinal materials in accordance...

Global and China Insulin Industry Report, 2013-2017

As the third largest human health disease following neoplastic disease, cardiovascular and cerebrovascular diseases, the number of diabetic patients has continued growing from 246 million in 2007 to 3...

China Large Volume Parenteral (LVP) Industry Report, 2013-2015

Under the context of China's medical reform and sustainable development of the pharmaceutical market, the output and demand of Large Volume Parenteral (LVP) which is one of the top five Chinese prepar...

China Vitamin Industry Report, 2012-2015

As a great power of vitamin production and export, China has long been known as the world’s vitamin production base. In recent years, its vitamin exports on external demand accounted for about 80% of ...

2005- All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号